The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients With High-Risk Prostate Cancer Treated with I-125 Brachytherapy as the Sole Radiation Therapeutic Modality

被引:0
|
作者
Ciezki, J. P. [1 ]
Reddy, C. A. [1 ]
Weller, M. A. [2 ]
Tendulkar, R. D. [1 ]
Stephans, K. L. [1 ]
Klein, E. A. [2 ]
Ulchaker, J. [2 ]
Angermeier, K. [2 ]
Campbell, S. [2 ]
Stephenson, A. J. [3 ]
机构
[1] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2535
引用
收藏
页码:E223 / E223
页数:1
相关论文
共 50 条
  • [41] Brachytherapy and Androgen-Deprivation Therapy in Patients With Intermediate- and High-Risk Prostate Cancer: Not Necessarily an Either/Or Decision
    Castro Mendez, Lucas
    Martell, Kevin
    Crook, Juanita M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (32) : 3820 - +
  • [42] Androgen deprivation therapy for prostate cancer and the risk of cardiac mortality
    Tsai, Henry K.
    D'Amico, Anthony V.
    Sadetsky, Natalia
    Chen, Ming-Hui
    Carroll, Peter R.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 125 - 126
  • [43] Androgen Deprivation Therapy in Patients Treated with External Beam Radiotherapy for High-risk Prostate Cancer in the PSA Era
    Vassil, A. D.
    Murphy, E. S.
    Robinson, C. G.
    Reddy, C. A.
    Chehade, N.
    Ciezki, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S82 - S82
  • [44] Impact of therapy on cancer metabolism in high-risk localized prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy
    Qu, Feng
    Gu, Yue
    Xue, Mengxia
    He, Mingzhe
    Zhou, Fang
    Wang, Guangji
    Peng, Ying
    PROSTATE, 2021, 81 (09): : 560 - 571
  • [45] EFFECT OF ANDROGEN-DEPRIVATION-THERAPY ON CARDIAC EVENTS IN PATIENTS TREATED WITH RADIATION THERAPY FOR PROSTATE CANCER
    Barry, Goy
    Janis, F. Yao
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [46] Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
    Yossepowitch, Ofer
    Eggener, Scott E.
    Serio, Angel M.
    Caruer, Brett S.
    Bianco, Fernando J., Jr.
    Scardino, Peter T.
    Eastham, James A.
    EUROPEAN UROLOGY, 2008, 53 (05) : 950 - 959
  • [47] A COMPETING RISK ANALYSIS OF CANCER-SPECIFIC MORTALITY OF INITIAL TREATMENT WITH RADICAL PROSTATECTOMY VERSUS RADIATION THERAPY IN HIGH-RISK PROSTATE CANCER
    Lee, Joo Yong
    Choi, Jae Hyeok
    Kim, In Kyoung
    Do Jung, Hae
    Kang, Ho Won
    Yoon, Young Eun
    Ha, Ji Yong
    Cho, Kang Su
    Lee, Joong Shik
    Cho, In Rae
    Choi, Young Deuk
    JOURNAL OF UROLOGY, 2014, 191 (04): : E719 - E720
  • [48] Radiation Therapy and Androgen Deprivation in the Management of High Risk Prostate Cancer REPLY
    不详
    INTERNATIONAL BRAZ J UROL, 2011, 37 (02): : 178 - 179
  • [49] The Impact of Brachytherapy on Prostate Cancer-Specific Mortality for Definitive Radiation Therapy of High-Grade Prostate Cancer: A Population-Based Analysis
    Shen, Xinglei
    Keith, Scott W.
    Mishra, Mark V.
    Dicker, Adam P.
    Showalter, Timothy N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04): : 1154 - 1159
  • [50] Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer treated with brachytherapy and supplemental external beam
    Allen, Z.
    Merrick, G. S.
    Butler, W.
    Wallner, K.
    Galbreath, R.
    Adamovich, E.
    Lief, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)